# US 2009/0270977 A1 · Stent fixation system

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2009/0270977 A1
- Document ID: US20090270977A1
- Status: Published application
- Kind: A1
- Application number: 12/430,212
- Filed: 2009-04-27
- Published: 2009-10-29
- Earliest claimed: 2008-04-26
- Assignees: Biotronik Vi Patent AG
- Inventors: Bettina Surber; Daniel Wintsch; Tommy Conzelmann; Nils Goetzen; Bodo Gerold; Alexander Borck
- Web page: https://patentgrep.com/patent/US20090270977A1

## CPC

- A61F 2/958: Inflatable balloons for placing stents or stent-grafts
- A61F 2002/9505: {having retaining means other than an outer sleeve, e.g. male-female connector between stent and instrument}
- A61F 2002/9583: {Means for holding the stent on the balloon, e.g. using protrusions, adhesives or an outer sleeve}
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

A stent fixation system 3 for fixation of a stent, comprising two retaining areas 10 which are connected by a connecting area 12 to form a fixation tubing. The retaining areas 10 provide a retaining structure which is designed to hold at least one stent strut 2 of the stent in the undilated state, such that the stent struts 2 are no longer in one of the retaining areas 10, at least in the dilated state of the stent.

## Claims

### Claim 1

A stent fixation system, comprising:
a) a retaining structure defined by a first retaining area and a second retaining area;
b) a connection area connecting the first and second retaining areas so as to form a fixation tubing; and,
c) at least one stent strut held,
whereby the at least one stent strut can be maintained by the retaining structure when the stent is in an undilated state by the fixation tubing and
whereby the at least one stent strut is substantially not in the first or second retaining areas when the stent is in a dilated state.

### Claim 2 (depends on 1)

The stent fixation system of claim 1, wherein the fixation tubing is formed from a thermoplastic poly-urethane (TPU).

### Claim 3 (depends on 1)

The stent fixation system of claim 1, wherein the connecting area has slots which form a network-like structure after dilatation of the stent.

### Claim 4 (depends on 1)

The stent fixation system of claim 1, wherein the connecting area is foldable.

### Claim 5 (depends on 1)

The stent fixation system of claim 1, wherein the stent fixation system is mountable either on a dilatation catheter or on an inner shaft of a catheter.

### Claim 6 (depends on 1)

The stent fixation system of claim 1, wherein the total length of the fixation tubing is greater than the length of the stent.

### Claim 7 (depends on 1)

The stent fixation system of claim 1, wherein the stent fixation system can be attached either to a balloon, to a balloon neck or to a catheter shaft.

### Claim 8 (depends on 1)

The stent fixation system of claim 1, further comprising at least one active pharmaceutical substance applied either to the retaining structure or to the entire stent fixation system.

### Claim 9 (depends on 8)

The stent fixation system of claim 8, wherein the at least one active pharmaceutical substance is applied either by immersion, dipping, spraying, doctor blade application, diffusion, coating or pressing.

### Claim 10 (depends on 8)

The stent fixation system of claim 8, wherein the at least one active pharmaceutical substance is applied together with either a vehicle or carrier.

### Claim 11 (depends on 8)

The stent fixation system of claim 8, wherein the at least one pharmaceutically active substance is a material selected from the group consisting of lipid regulators, immunosuppressants, vasodilatators, calcium channel blockers, calcineurin inhibitors), antiphlogistics, anti-inflammatories, antiallergics, oligonucleotides, estrogens, endothelial cell-producing agents, steroids, proteins, peptides, proliferation inhibitors, analgesics, antirheumatics, angiogenesis inhibitors and cytostatics.
